| Literature DB >> 35151508 |
Özlem Akgün1, Gülşah Kavrul Kayaalp1, Fatma Gül Demirkan1, Figen Çakmak1, Ayşe Tanatar1, Vafa Guliyeva1, Hafize Emine Sönmez2, Nuray Aktay Ayaz3.
Abstract
BACKGROUND: Vaccination programs are effective strategies in preventing infectious diseases and controlling epidemics. Vaccination against SARS-CoV-2 in children has not yet been approved globally, and it is unclear what attitude families will take when it is approved in children. We aimed to investigate the underlying causes of vaccine acceptance, hesitation, and refusal, as well as concerns about the acceptability of the COVID-19 vaccine by parents of children with rheumatic diseases.Entities:
Keywords: COVID-19; COVID-19 vaccine; Pediatric rheumatic disease; Vaccine acceptance; Vaccine hesitancy
Mesh:
Substances:
Year: 2022 PMID: 35151508 PMCID: PMC8813553 DOI: 10.1016/j.vaccine.2022.01.061
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 4.169
Demographics, socioeconomic and household vaccination status of participants.
| Characteristics | N = number | n=% | Vaccine accept (p value) | |
|---|---|---|---|---|
| Female | 111 | 55.2 | ||
| Male | 90 | 44.8 | ||
| ≤5 years old | 13 | 6.5 | ||
| 6–11 years old | 83 | 41.3 | ||
| 12–18 years old | 105 | 52.2 | ||
| 20–35 years old | 73 | 36.3 | ||
| 36–45 years old | 99 | 49.3 | ||
| >45 years old | 29 | 14.4 | ||
| 20–35 years old | 32 | 15.9 | ||
| 36–45 years old | 114 | 56.7 | ||
| >45 years old | 55 | 27.4 | ||
| Primary education | 119 | 59.2 | ||
| High school (lycee) | 49 | 24.4 | ||
| University, graduate | 33 | 16.4 | ||
| Primary education | 136 | 67.7 | ||
| High school (lycee) | 39 | 19.4 | ||
| University, graduate | 26 | 12.9 | ||
| <5000 TL (€478) | 144 | 71.6 | ||
| >5000 TL (€478) | 57 | 28.4 | ||
| Yes | 24 | 11.9 | ||
| No | 177 | 88.1 | ||
| 4 or less | 104 | 51,7 | ||
| 5 or more | 97 | 48,3 |
Questions regarding compliance with COVID-19 disease, general health information of children and pandemic measures.
| Yes | 185 | 92 | ||
| No | 15 | 8 | ||
| Yes | 9 | 4,5 | ||
| No | 192 | 95,5 | ||
| Fatal | 151 | 75.1 | ||
| Worse than the flu | 44 | 21,9 | ||
| Like the flu | 6 | 3 | ||
| Yes | 131 | 65.2 | ||
| No | 70 | 34.8 | ||
| Did not happen | 89 | 44.3 | ||
| Household, relatives | 62 | 30.8 | ||
| Friend, neighbor | 50 | 24.9 | ||
| Yes | 198 | 98.5 | ||
| No | 3 | 1.5 | ||
| Yes | 190 | 94,5 | ||
| No | 11 | 5,5 | ||
| Yes | 113 | 56.2 | ||
| No | 88 | 43.8 | ||
| Yes | 70 | 34.8 | ||
| No | 131 | 65.2 | ||
| Yes | 185 | 92 | ||
| No | 16 | 8 | ||
| Everyday | 135 | 67.2 | ||
| One or two days a week | 48 | 23.9 | ||
| Once in a week | 5 | 2.5 | ||
| I don't particularly follow. | 13 | 6.5 |
COVID-19, Coronavirus disease 2019.
Fig. 1Causes of vaccine accept and refuse, obtaining route of COVID-19 information.
Fig. 2Acceptance, refuse, and hesitancy of parents for themselves and their children.
COVID-19 vaccination status of closed circle of parents.
| n/N | P value | ||
|---|---|---|---|
| 56.2% | 45/201 | 0.79 | |
| 34.8% | 70/201 | 0.24 | |
| 12.8% | 9/70 | 0.64 (Fisher’s exact) |
COVID-19, Coronavirus disease 2019
Affecting factors of COVID-19 vaccine embracement.
| Univariate regression model | Multivariate regression model | |||||
|---|---|---|---|---|---|---|
| May a pandemic be prevented with a vaccine? | 8.17 | 3.04–21.99 | <0.001 | 8.84 | 2.80–27.85 | <0.001 |
| Did your child receive their antirheumatic drugs regularly during the pandemic process? | 4.98 | 1.37–18.09 | 0.014 | 5.40 | 1.10–26.33 | 0.037 |
| Did your child have the recommended vaccines that are not included in the national vaccination calendar? | 3.63 | 1.24–10.59 | 0.018 | 4.12 | 1.12–15.08 | 0.032 |
| Did you fully comply with the pandemic measures? | 3.16 | 1.15–8.71 | 0.026 | 5.24 | 1.46–18.74 | 0.011 |
| Did you pay attention to hand hygiene? | 15.8 | 1.67–148.95 | 0.016 | |||
| Did you avoid social and meal gatherings with other people than those living in the same house? | 2.57 | 1.00–6.61 | 0.05 | |||
OR, odds ratio; CI, confidence interval; P value, statistical significance.